New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

[1]  Katelyn A. Reed,et al.  Renal Neoplasia with Papillary Architecture Involving the Pelvicalyceal System. , 2020, Human pathology.

[2]  M. Tretiakova,et al.  Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including its Variant Morphologies. , 2020, Advances in anatomic pathology.

[3]  V. Reuter,et al.  Adverse Histology, Homozygous Loss of CDKN2A/B, and Complex Genomic Alterations in Locally Advanced / Metastatic Renal Mucinous Tubular and Spindle Cell Carcinoma , 2020, Modern Pathology.

[4]  Zhongliang Hu,et al.  FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome–based outlier mining and immunohistochemistry , 2020, Virchows Archiv.

[5]  T. Molina,et al.  MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features , 2020, Modern Pathology.

[6]  H. Zeng,et al.  Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis , 2020, Journal of Clinical Pathology.

[7]  Jesse S. Voss,et al.  Secondary Renal Neoplasia Following Chemotherapy or Radiation in Pediatric Patients. , 2020, Human pathology.

[8]  P. D. Dal Cin,et al.  Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes , 2020, Histopathology.

[9]  G. De Velasco,et al.  Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome , 2020, Modern Pathology.

[10]  C. Porta,et al.  Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial , 2020, Journal for ImmunoTherapy of Cancer.

[11]  S. Menon,et al.  Mucinous tubular and spindle cell carcinoma of the kidney: A case series with a brief review of the literature , 2020, Indian journal of cancer.

[12]  T. Guzzo,et al.  Acquired Cystic Kidney Disease–associated Renal Cell Carcinoma (ACKD-RCC) Harbor Recurrent Mutations in KMT2C and TSC2 Genes , 2020, The American journal of surgical pathology.

[13]  Yuehua Wu,et al.  Sporadic Oncocytic Tumors with Features Intermediate between Oncocytoma and Chromophobe Renal Cell Carcinoma: Comprehensive Clinico-Pathological and Genomic Profiling , 2020, medRxiv.

[14]  C. Pan,et al.  ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217 , 2020, Modern Pathology.

[15]  Y. Oda,et al.  The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features , 2020, Virchows Archiv.

[16]  Chaofu Wang,et al.  Papillary Renal Neoplasm With Reverse Polarity: A Clinicopathologic Study of 7 Cases , 2020, International journal of surgical pathology.

[17]  Y. Oda,et al.  PD-L1/IDO1 expression and tumor-infiltrating lymphocyte status in renal cell carcinoma with sarcomatoid changes and rhabdoid features. , 2020, Human pathology.

[18]  P. Abbosh,et al.  Novel Biomarkers in Chromophobe Renal Cell Carcinoma: Distinguishing it from its Mimics. , 2020, European urology.

[19]  I. Wistuba,et al.  Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma. , 2020, Cancer cell.

[20]  S. Dhanasekaran,et al.  Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms. , 2020, European urology.

[21]  I. Pedrosa,et al.  Pancreatic tropism of metastatic renal cell carcinoma. , 2020, JCI insight.

[22]  Mark W. Ball,et al.  Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments , 2020, Genes, chromosomes & cancer.

[23]  M. Amin,et al.  Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease–associated Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic Lesions , 2020, The American journal of surgical pathology.

[24]  D. Grignon,et al.  Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer. , 2020, The American journal of surgical pathology.

[25]  P. Argani,et al.  BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition , 2020, Cold Spring Harbor molecular case studies.

[26]  R. Motzer,et al.  Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression , 2020, Clinical Cancer Research.

[27]  P. Humphrey,et al.  High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis , 2020, The American journal of surgical pathology.

[28]  T. Antic,et al.  Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous , 2020, The American journal of surgical pathology.

[29]  Bin Yang,et al.  Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically , 2020, BMC Urology.

[30]  M. Troxell,et al.  Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution , 2020, Histopathology.

[31]  E. Compérat,et al.  Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomas , 2020, Modern Pathology.

[32]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[33]  M. Atkins,et al.  Checkpoint inhibitor immunotherapy in kidney cancer , 2020, Nature Reviews Urology.

[34]  S. Fan,et al.  Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei , 2020, Histopathology.

[35]  J. Cheville,et al.  Defining clear cell papillary renal cell carcinoma in routine clinical practice , 2020, Histopathology.

[36]  T. Ho,et al.  Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers , 2020, Scientific Reports.

[37]  Y. Cho,et al.  Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity—a comparative study with papillary renal cell carcinoma , 2020, Modern Pathology.

[38]  C. Antonescu,et al.  A novel RBMX‐TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid cell tumor , 2020, Genes, chromosomes & cancer.

[39]  R. Shah,et al.  “Renal Cell Carcinoma With Leiomyomatous Stroma” Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity , 2019, The American journal of surgical pathology.

[40]  J. Cadeddu,et al.  Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type , 2019, EBioMedicine.

[41]  H. Yokoo,et al.  A case of renal cell carcinoma unclassified with medullary phenotype without detectable gene deletion , 2019, Pathology international.

[42]  W. Linehan,et al.  Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights. , 2019, European urology.

[43]  Y. Nagashima,et al.  Birt‐Hogg‐Dubé syndrome‐associated renal cell carcinoma: Histopathological features and diagnostic conundrum , 2019, Cancer science.

[44]  A. Gill,et al.  Morphologic Clues to Succinate Dehydrogenase (SDH) Deficiency in Pheochromocytomas and Paragangliomas. , 2019, The American journal of surgical pathology.

[45]  Ming Zhao,et al.  Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs) , 2019, The American journal of surgical pathology.

[46]  G. Freeman,et al.  Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  Chad A. LaGrange,et al.  NCCN Guidelines Insights: Kidney Cancer, Version 2.2020. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[48]  M. Ladanyi,et al.  TFEB Expression Profiling in Renal Cell Carcinomas , 2019, The American journal of surgical pathology.

[49]  T. Miyazaki,et al.  Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype , 2019, Cancers.

[50]  A. Miyajima,et al.  Impact of rhabdoid differentiation on postoperative outcome for patients with N0M0 renal cell carcinoma. , 2019, Urologic oncology.

[51]  D. Grignon,et al.  Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity , 2019, Modern Pathology.

[52]  M. Zhou,et al.  A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients , 2019, The American journal of surgical pathology.

[53]  J. Cheville,et al.  Incidence of Succinate Dehydrogenase and Fumarate Hydratase-Deficient Renal Cell Carcinoma Based on Immunohistochemical Screening with SDHA/SDHB and FH/2SC. , 2019, Human pathology.

[54]  P. Argani,et al.  Metanephric Adenoma–Epithelial Wilms Tumor Overlap Lesions , 2019, The American journal of surgical pathology.

[55]  R. Motzer,et al.  Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes. , 2019, Clinical genitourinary cancer.

[56]  S. Rais-Bahrami,et al.  Clear Cell Papillary Renal Cell Carcinoma: Molecular Profile and Virtual Karyotype. , 2019, Human pathology.

[57]  R. Motzer,et al.  Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes. , 2019, Clinical genitourinary cancer.

[58]  J. Cheville,et al.  JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management , 2019, Modern Pathology.

[59]  Lauren L. Ritterhouse,et al.  Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma , 2019, The American journal of surgical pathology.

[60]  Scott R. Kennedy,et al.  Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma , 2019, eLife.

[61]  V. Reuter,et al.  Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases , 2019, Modern Pathology.

[62]  Francis Deng,et al.  Tubulocystic renal cell carcinoma , 2019, Radiopaedia.org.

[63]  J. Blay,et al.  Successful Treatment of Metastatic Adult Wilms Tumor With Anti-BRAF Treatment: A Case Report and a Brief Review of the Literature. , 2019, Clinical genitourinary cancer.

[64]  E. Compérat,et al.  Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cells , 2019, Histopathology.

[65]  W. Linehan,et al.  Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma. , 2019, Clinical genitourinary cancer.

[66]  R. Alaghehbandan,et al.  Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases. , 2019, Annals of diagnostic pathology.

[67]  V. Reuter,et al.  Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile , 2019, Modern Pathology.

[68]  A. Patchefsky,et al.  NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma , 2019, Modern Pathology.

[69]  Liang Cheng,et al.  Renal cell carcinoma staging: pitfalls, challenges, and updates , 2019, Histopathology.

[70]  K. Trpkov,et al.  New and emerging renal entities: a perspective post‐WHO 2016 classification , 2019, Histopathology.

[71]  Y. Nagashima,et al.  A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion , 2018, Virchows Archiv.

[72]  Thomas P. Howard,et al.  Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition , 2018, bioRxiv.

[73]  S. Dhanasekaran,et al.  VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney , 2018, The American journal of surgical pathology.

[74]  Yingbei Chen,et al.  Clues to recognition of fumarate hydratase‐deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples , 2018, Cancer cytopathology.

[75]  P. Argani,et al.  Acquired Cystic Disease-associated Renal Cell Carcinoma (ACKD-RCC)-like Cysts , 2018, The American journal of surgical pathology.

[76]  R. Tothill,et al.  Bayesian approach to determining penetrance of pathogenic SDH variants , 2018, Journal of Medical Genetics.

[77]  T. Tsuzuki,et al.  Acquired cystic disease‐associated renal cell carcinoma is the most common subtype in long‐term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi‐institutional study , 2018, Pathology international.

[78]  P. Mei,et al.  Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases , 2018, Diagnostic Pathology.

[79]  C. Rogers,et al.  Pathological staging of renal cell carcinoma: a review of 300 consecutive cases with emphasis on retrograde venous invasion , 2018, Histopathology.

[80]  A. Renshaw,et al.  Fine‐needle aspiration of tubulocystic renal cell carcinoma , 2018, Diagnostic cytopathology.

[81]  D. Berney,et al.  SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients. , 2018, Human pathology.

[82]  V. Reuter,et al.  Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features , 2018, The American journal of surgical pathology.

[83]  H. Lai,et al.  Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges , 2018, AntiCancer Research.

[84]  A. Sangoi,et al.  Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up , 2018, The American journal of surgical pathology.

[85]  Charles J. Vaske,et al.  Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study , 2018, Modern Pathology.

[86]  Steven C. Smith,et al.  High grade infiltrative adenocarcinomas of renal cell origin: New insights into classification, morphology, and molecular pathogenesis , 2018, Pathology international.

[87]  G. Mayhew,et al.  Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal , 2018, Cell.

[88]  P. A. Futreal,et al.  Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal , 2018, Cell.

[89]  Paul T. Spellman,et al.  The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma , 2018, Cell reports.

[90]  D. Prapotnich,et al.  Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems , 2018, The American journal of surgical pathology.

[91]  N. Rioux-Leclercq,et al.  Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases , 2018, Histopathology.

[92]  Xiao-jun Zhou,et al.  Novel gene fusion of PRCC–MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH , 2018, Histopathology.

[93]  S. Fox,et al.  SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response , 2018, npj Precision Oncology.

[94]  P. Argani,et al.  Re‐evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patients , 2018, Histopathology.

[95]  C. Walker,et al.  A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma , 2018, Clinical Cancer Research.

[96]  C. Genestie,et al.  Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration , 2018, Modern Pathology.

[97]  A. Gill.  Succinate dehydrogenase (SDH)‐deficient neoplasia , 2018, Histopathology.

[98]  A. Tischler,et al.  Pathology and genetics of phaeochromocytoma and paraganglioma , 2018, Histopathology.

[99]  I. Wistuba,et al.  Programmed cell death ligand 1 and tumor‐infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation , 2017, Cancer.

[100]  P. Tamboli,et al.  Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study , 2017, BJU international.

[101]  C. Genestie,et al.  Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers , 2017, Clinical genetics.

[102]  A. Evans,et al.  Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis , 2017, The American journal of surgical pathology.

[103]  R. Alaghehbandan,et al.  Chromosomal numerical aberration pattern in papillary renal cell carcinoma: Review article. , 2017, Annals of Diagnostic Pathology.

[104]  S. Rais-Bahrami,et al.  Pathologic and clinical characteristics of early onset renal cell carcinoma. , 2017, Human pathology.

[105]  P. Argani,et al.  Chromosomal abnormalities of high‐grade mucinous tubular and spindle cell carcinoma of the kidney , 2017, Histopathology.

[106]  R. Mehra,et al.  Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma. , 2017, Human pathology.

[107]  N. Palanisamy,et al.  Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database , 2017, Modern Pathology.

[108]  K. Baggerly,et al.  Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape , 2017, Clinical Cancer Research.

[109]  Yingbei Chen,et al.  A distinctive, low‐grade oncocytic fumarate hydratase‐deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase‐deficient renal cell carcinoma , 2017, Histopathology.

[110]  J. Cheville,et al.  Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma. , 2017, JCI insight.

[111]  Erika J. Thompson,et al.  Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas , 2017, Histopathology.

[112]  J. López,et al.  Multisite tumor sampling: a new tumor selection method to enhance intratumor heterogeneity detection. , 2017, Human pathology.

[113]  C. Antonescu,et al.  RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH , 2017, The American journal of surgical pathology.

[114]  Xiao-jun Zhou,et al.  Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3 , 2017, The American journal of surgical pathology.

[115]  B. Delahunt,et al.  Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists. , 2017, Human pathology.

[116]  R. Alaghehbandan,et al.  Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases. , 2017, Annals of diagnostic pathology.

[117]  Sarah H. Johnson,et al.  TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management , 2017, Modern Pathology.

[118]  Dibson D. Gondim,et al.  Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis? , 2017, The American journal of surgical pathology.

[119]  R. Pulido,et al.  CD34 immunostaining enhances a distinct pattern of intratumor angiogenesis with prognostic implications in clear cell renal cell carcinoma , 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[120]  L. Egevad,et al.  Rhabdoid and Undifferentiated Phenotype in Renal Cell Carcinoma: Analysis of 32 Cases Indicating a Distinctive Common Pathway of Dedifferentiation Frequently Associated With SWI/SNF Complex Deficiency , 2017, The American journal of surgical pathology.

[121]  S. Gadd,et al.  BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors. , 2017, Human pathology.

[122]  S. Rais-Bahrami,et al.  Clear Cell Papillary Renal Cell Carcinoma: New Clinical and Imaging Characteristics. , 2017, Urology.

[123]  J. Epstein,et al.  Renal oncocytoma with vascular invasion: a series of 22 cases. , 2016, Human pathology.

[124]  S. Dhanasekaran,et al.  Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney. , 2016, Cancer discovery.

[125]  F. Nomura,et al.  Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt–Hogg–Dubé syndrome , 2016, Clinical genetics.

[126]  A. Evans,et al.  Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy. , 2016, European urology focus.

[127]  N. Schultz,et al.  Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets , 2016, Nature Communications.

[128]  V. Reuter,et al.  Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma , 2016, The American journal of surgical pathology.

[129]  P. Stephens,et al.  Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling. , 2016, European urology.

[130]  C. Antonescu,et al.  TFEB-amplified Renal Cell Carcinomas: An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity , 2016, The American journal of surgical pathology.

[131]  N. Rioux-Leclercq,et al.  Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney Carcinomas , 2016, Scientific Reports.

[132]  Ming Zhou,et al.  Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases , 2016, Applied immunohistochemistry & molecular morphology : AIMM.

[133]  P. Stephens,et al.  Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations. , 2016, European urology.

[134]  B. Krušlin,et al.  Solid papillary renal cell carcinoma: clinicopathologic, morphologic, and immunohistochemical analysis of 10 cases and review of the literature. , 2016, Annals of diagnostic pathology.

[135]  Kristin M. Post,et al.  Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation , 2016, Oncotarget.

[136]  S. Dhanasekaran,et al.  Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of Neoplasms , 2016, The American journal of surgical pathology.

[137]  D. Berney,et al.  Fumarate Hydratase–deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome , 2016, The American journal of surgical pathology.

[138]  C. Tournigand,et al.  Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas. , 2016, European urology.

[139]  C. Antonescu,et al.  TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers , 2016, The American journal of surgical pathology.

[140]  D. Grignon,et al.  Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma , 2016, Histopathology.

[141]  P. Argani,et al.  Frequent BRAF V600E Mutations in Metanephric Stromal Tumor. , 2016, The American journal of surgical pathology.

[142]  A. Agaimy,et al.  Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma? , 2016, The American journal of surgical pathology.

[143]  P. Tamboli,et al.  Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre , 2016, BJU international.

[144]  C. Morrison,et al.  Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation , 2016, Oncotarget.

[145]  T. Dwight,et al.  Fumarate Hydratase–deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings , 2016, The American journal of surgical pathology.

[146]  Chris Sander,et al.  Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. , 2016, Cell reports.

[147]  Y. Nagashima,et al.  Genome-Wide Uniparental Disomy and Copy Number Variations in Renal Cell Carcinomas Associated with Birt-Hogg-Dubé Syndrome. , 2016, The American journal of pathology.

[148]  J. McKenney,et al.  Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution , 2016, The American journal of surgical pathology.

[149]  K. Trpkov,et al.  Cystic Renal Oncocytoma and Tubulocystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Comparative Study , 2016, Applied immunohistochemistry & molecular morphology : AIMM.

[150]  Steven J. M. Jones,et al.  Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. , 2016, The New England journal of medicine.

[151]  A. Sangoi,et al.  Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women , 2016, The American journal of surgical pathology.

[152]  G. Netto,et al.  Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma. , 2015, Human pathology.

[153]  R. Mehra,et al.  Emerging Entities in Renal Neoplasia. , 2015, Surgical pathology clinics.

[154]  J. Epstein,et al.  Atypical Renal Cysts: A Morphologic, Immunohistochemical, and Molecular Study , 2015, The American journal of surgical pathology.

[155]  D. Grignon,et al.  Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis , 2015, The American journal of surgical pathology.

[156]  W. Linehan,et al.  Molecular genetics and clinical features of Birt–Hogg–Dubé syndrome , 2015, Nature Reviews Urology.

[157]  Yingyong Hou,et al.  A novel germline mutation in SDHA identified in a rare case of gastrointestinal stromal tumor complicated with renal cell carcinoma. , 2015, International journal of clinical and experimental pathology.

[158]  C. Jackson,et al.  Application of BRAF V600E mutation analysis for the diagnosis of metanephric adenofibroma. , 2015, The American journal of surgical pathology.

[159]  Ming Zhao,et al.  Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature. , 2015, International journal of clinical and experimental pathology.

[160]  Xiao-jun Zhou,et al.  PSF/SFPQ Is a Very Common Gene Fusion Partner in TFE3 Rearrangement–associated Perivascular Epithelioid Cell Tumors (PEComas) and Melanotic Xp11 Translocation Renal Cancers: Clinicopathologic, Immunohistochemical, and Molecular Characteristics Suggesting Classification as a Distinct Entity , 2015, The American journal of surgical pathology.

[161]  A. Lopez‐Beltran,et al.  BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies , 2015, Expert review of molecular diagnostics.

[162]  T. Ho,et al.  PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation , 2015, Cancer Immunology Research.

[163]  O. Hes,et al.  Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma. , 2015, Annals of diagnostic pathology.

[164]  P. Thorner,et al.  BRAF mutations in pediatric metanephric tumors. , 2015, Human pathology.

[165]  N. Dimitrova,et al.  Identification of a novel PARP14‐TFE3 gene fusion from 10‐year‐old FFPE tissue by RNA‐seq , 2015, Genes, chromosomes & cancer.

[166]  W. Linehan,et al.  Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors , 2015, Modern Pathology.

[167]  J. Cheville,et al.  Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma. , 2015, European urology.

[168]  R. Vikram,et al.  Mucinous Tubular and Spindle Cell Carcinoma ( MTSCC ) of the Kidney : A Detailed Study of Radiologic , Pathologic and Clinical Outcomes 1 , 2014 .

[169]  Narasimhan P. Agaram,et al.  Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications , 2015, The American journal of surgical pathology.

[170]  J. Ross,et al.  A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling , 2015, The American journal of surgical pathology.

[171]  E. Chamorey,et al.  Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases , 2015, Genes, chromosomes & cancer.

[172]  A. Gill,et al.  Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC) , 2015, Virchows Archiv.

[173]  K. Baggerly,et al.  Intratumoral Morphologic and Molecular Heterogeneity of Rhabdoid Renal Cell Carcinoma: Challenges for Personalized Therapy , 2015, Modern Pathology.

[174]  F. Kawakami,et al.  Review of renal cell carcinoma with rhabdoid features with focus on clinical and pathobiological aspects. , 2015, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[175]  S. Signoretti,et al.  Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma , 2015, Histopathology.

[176]  David C. Miller,et al.  Molecular and Immunohistochemical Characterization Reveals Novel BRAF Mutations in Metanephric Adenoma , 2015, The American journal of surgical pathology.

[177]  R. Mehra,et al.  Metastases to the kidney: a clinicopathological study of 43 cases with an emphasis on deceptive features , 2015, Histopathology.

[178]  J. Cheville,et al.  A novel prognostic model for patients with sarcomatoid renal cell carcinoma , 2015, BJU international.

[179]  M. Brunelli,et al.  Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature. , 2014, Annals of diagnostic pathology.

[180]  R. Montironi,et al.  Renal cell carcinoma with rhabdoid features and loss of INI1 expression in an individual without sickle cell trait. , 2014, Pathology.

[181]  Lisa N Kinch,et al.  Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes , 2014, Nature Genetics.

[182]  J. McKenney,et al.  Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma: A Morphologically Distinct Entity , 2014, The American journal of surgical pathology.

[183]  R. Bennett,et al.  A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment , 2014, Genetics in Medicine.

[184]  A. Sangoi,et al.  Tuberous Sclerosis–associated Renal Cell Carcinoma: A Clinicopathologic Study of 57 Separate Carcinomas in 18 Patients , 2014, The American journal of surgical pathology.

[185]  Lawrence A. Donehower,et al.  The somatic genomic landscape of chromophobe renal cell carcinoma. , 2014, Cancer cell.

[186]  P. Tamboli,et al.  Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases. , 2014, Human pathology.

[187]  J. McKenney,et al.  Rhabdoid Differentiation Is Associated With Aggressive Behavior in Renal Cell Carcinoma: A Clinicopathologic Analysis of 76 Cases With Clinical Follow-up , 2014, The American journal of surgical pathology.

[188]  W. Linehan,et al.  Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment , 2014, Familial Cancer.

[189]  L. Nie,et al.  Gains of chromosomes 7 and 17 in tubulocystic carcinoma of kidney: two cases with fluorescence in situ hybridisation analysis , 2014, Journal of Clinical Pathology.

[190]  M. Latour,et al.  The Morphologic and Immunohistochemical Spectrum of Papillary Renal Cell Carcinoma: Study Including 132 Cases With Pure Type 1 and Type 2 Morphology As Well As Tumors With Overlapping Features , 2014, The American journal of surgical pathology.

[191]  T. Antic,et al.  Pathologic spectrum of cysts in end-stage kidneys: possible precursors to renal neoplasia. , 2014, Human pathology.

[192]  J. Brugarolas.  Molecular genetics of clear-cell renal cell carcinoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[193]  M. Ladanyi,et al.  Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage , 2014, Modern Pathology.

[194]  J. Epstein,et al.  Papillary Cystadenoma of the Epididymis and Broad Ligament: Morphologic and Immunohistochemical Overlap With Clear Cell Papillary Renal Cell Carcinoma , 2014, The American journal of surgical pathology.

[195]  P. Argani,et al.  t(6;11) Renal Cell Carcinoma (RCC): Expanded Immunohistochemical Profile Emphasizing Novel RCC Markers and Report of 10 New Genetically Confirmed Cases , 2014, The American journal of surgical pathology.

[196]  M. Berger,et al.  Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal Cancer: Recognition of the Syndrome by Pathologic Features and the Utility of Detecting Aberrant Succination by Immunohistochemistry , 2014, The American journal of surgical pathology.

[197]  D. Grignon,et al.  Clear cell renal cell carcinoma with a syncytial-type multinucleated giant tumor cell component: implications for differential diagnosis. , 2014, Human pathology.

[198]  Q. Shen,et al.  Coexistent loss of INI1 and BRG1 expression in a rhabdoid renal cell carcinoma (RCC): implications for a possible role of SWI/SNF complex in the pathogenesis of RCC. , 2014, International journal of clinical and experimental pathology.

[199]  T. Dwight,et al.  Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas , 2014, The American journal of surgical pathology.

[200]  K. Bensalah,et al.  BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma. , 2014, The Journal of urology.

[201]  W. Linehan,et al.  Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[202]  L. Lipton,et al.  Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma. , 2013, Pathology.

[203]  W. Linehan,et al.  Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. , 2013, The Journal of urology.

[204]  R. Grobholz,et al.  Collecting Duct Carcinomas Represent a Unique Tumor Entity Based on Genetic Alterations , 2013, PloS one.

[205]  Lars Egevad,et al.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia , 2013, The American journal of surgical pathology.

[206]  B. Delahunt,et al.  Handling and Staging of Renal Cell Carcinoma: The International Society of Urological Pathology Consensus (ISUP) Conference Recommendations , 2013, The American journal of surgical pathology.

[207]  J. Cheville,et al.  The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters , 2013, The American journal of surgical pathology.

[208]  M. Ladanyi,et al.  Utilization of a TFE3 Break-apart FISH Assay in a Renal Tumor Consultation Service , 2013, The American journal of surgical pathology.

[209]  D. Grignon,et al.  Clear Cell Papillary Renal Cell Carcinoma–like Tumors in Patients With Von Hippel-Lindau Disease Are Unrelated to Sporadic Clear Cell Papillary Renal Cell Carcinoma , 2013, The American journal of surgical pathology.

[210]  J. Brugarolas,et al.  Cooperation and antagonism among cancer genes: the renal cancer paradigm. , 2013, Cancer research.

[211]  J. Epstein,et al.  Tubulocystic carcinoma of the kidney with poorly differentiated foci: a series of 3 cases with fluorescence in situ hybridization analysis. , 2013, Human pathology.

[212]  J. McKenney,et al.  Hereditary Syndromes With Associated Renal Neoplasia: A Practical Guide to Histologic Recognition in Renal Tumor Resection Specimens , 2013, Advances in anatomic pathology.

[213]  The Cancer Genome Atlas Research Network.  COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA , 2013, Nature.

[214]  G. Gyapay,et al.  Germline BAP1 mutations predispose to renal cell carcinomas. , 2013, American journal of human genetics.

[215]  O. Hes,et al.  Renal hybrid oncocytic/chromophobe tumors - a review. , 2013, Histology and histopathology.

[216]  Han Liu,et al.  Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. , 2013, European urology.

[217]  Carmen L. Wilson,et al.  Renal carcinoma after childhood cancer: a report from the childhood cancer survivor study. , 2013, Journal of the National Cancer Institute.

[218]  C. Drachenberg,et al.  Tubulocystic carcinoma of the kidney: a histologic, immunohistochemical, and ultrastructural study , 2013, Virchows Archiv.

[219]  Stephen A Boorjian,et al.  A Novel Grading System for Clear Cell Renal Cell Carcinoma Incorporating Tumor Necrosis , 2013, The American journal of surgical pathology.

[220]  W. Linehan,et al.  Renal Medullary Carcinoma: Molecular, Immunohistochemistry, and Morphologic Correlation , 2013, The American journal of surgical pathology.

[221]  L. Lipton,et al.  Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors , 2013, The American journal of surgical pathology.

[222]  P. Kapur,et al.  Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. , 2013, The Lancet. Oncology.

[223]  Y. Nakatani,et al.  Birt–Hogg–Dubé syndrome: clinicopathological features of the lung , 2012, Journal of Clinical Pathology.

[224]  P. Kantoff,et al.  BRAF mutations in metanephric adenoma of the kidney. , 2012, European urology.

[225]  M. Ladanyi,et al.  Molecular Confirmation of t(6;11)(p21;q12) Renal Cell Carcinoma in Archival Paraffin-embedded Material Using a Break-apart TFEB FISH Assay Expands its Clinicopathologic Spectrum , 2012, The American journal of surgical pathology.

[226]  C. Fisher,et al.  Metastatic renal mucinous tubular and spindle cell carcinoma. Atypical behavior of a rare, morphologically bland tumor. , 2012, Annals of diagnostic pathology.

[227]  O. Delattre,et al.  SMARCB1/INI1 inactivation in renal medullary carcinoma , 2012, Histopathology.

[228]  R. Shah,et al.  Carcinoma of the Collecting Ducts of Bellini and Renal Medullary Carcinoma: Clinicopathologic Analysis of 52 Cases of Rare Aggressive Subtypes of Renal Cell Carcinoma With a Focus on Their Interrelationship , 2012, The American journal of surgical pathology.

[229]  A. Gill.  Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia , 2012, Pathology.

[230]  N. Grishin,et al.  BAP1 loss defines a new class of renal cell carcinoma , 2012, Nature Genetics.

[231]  J. Cheville,et al.  TFE3 Rearrangements in Adult Renal Cell Carcinoma: Clinical and Pathologic Features With Outcome in a Large Series of Consecutively Treated Patients , 2012, The American journal of surgical pathology.

[232]  P. Tamboli,et al.  Expression of OCT3/4 in Renal Medullary Carcinoma Represents a Potential Diagnostic Pitfall , 2012, The American journal of surgical pathology.

[233]  Ximing J. Yang,et al.  Expression of carbonic anhydrase IX in genitourinary and adrenal tumours , 2011, Histopathology.

[234]  M. Tamura,et al.  High-grade mucinous tubular and spindle cell carcinoma: comparative genomic hybridization study. , 2011, Annals of diagnostic pathology.

[235]  S. Bonsib,et al.  Retrograde venous invasion in renal cell carcinoma: a complication of sinus vein and main renal vein invasion , 2011, Modern Pathology.

[236]  T. Thamboo,et al.  Unique case of tubulocystic carcinoma of the kidney with sarcomatoid features: a new entity. , 2011, Urology.

[237]  M. Ladanyi,et al.  Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions , 2011, Modern Pathology.

[238]  A. Chou,et al.  Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology , 2011, The American journal of surgical pathology.

[239]  M. Rubin,et al.  Validation of a TFE3 Break-apart FISH Assay for Xp11.2 Translocation Renal Cell Carcinomas , 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[240]  M. Rosenblum,et al.  Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel–Lindau gene and hypoxia-inducible factor pathway-related proteins , 2011, Modern Pathology.

[241]  W. Dinjens,et al.  SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. , 2011, The Journal of clinical endocrinology and metabolism.

[242]  P. Russo,et al.  Role of Immunohistochemistry in the Evaluation of Needle Core Biopsies in Adult Renal Cortical Tumors: An Ex Vivo Study , 2011, The American journal of surgical pathology.

[243]  P. Russo,et al.  Chromophobe Renal Cell Carcinoma: A Clinicopathologic Study of 203 Tumors in 200 Patients With Primary Resection at a Single Institution , 2011, The American journal of surgical pathology.

[244]  M. Sibony,et al.  Clear‐cell papillary renal cell carcinoma: 24 cases of a distinct low‐grade renal tumour and a comparative genomic hybridization array study of seven cases , 2011, Histopathology.

[245]  M. O'sullivan,et al.  Rhabdomyosarcoma-Associated Renal Cell Carcinoma: A Link with Constitutional TP53 Mutation , 2011, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[246]  J. Srigley,et al.  Mucinous tubular and spindle cell carcinoma of kidney without sarcomatoid change showing metastases to liver and retroperitoneal lymph node. , 2011, Human pathology.

[247]  P. Argani,et al.  Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade. , 2010, American journal of clinical pathology.

[248]  K. Trpkov,et al.  Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features , 2010, Histopathology.

[249]  T. Shuin,et al.  Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y , 2010, Medical Molecular Morphology.

[250]  M. Ladanyi,et al.  A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions , 2010, The American journal of surgical pathology.

[251]  W. Linehan,et al.  Dual-color, Break-apart FISH Assay on Paraffin-embedded Tissues as an Adjunct to Diagnosis of Xp11 Translocation Renal Cell Carcinoma and Alveolar Soft Part Sarcoma , 2010, The American journal of surgical pathology.

[252]  C. Stolle,et al.  Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30‐year‐old mystery , 2010, American journal of medical genetics. Part A.

[253]  Ximing J. Yang,et al.  Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma , 2010, BMC Cancer.

[254]  W. Linehan,et al.  The genetic basis of kidney cancer: a metabolic disease , 2010, Nature Reviews Urology.

[255]  J. Cheville,et al.  Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. , 2010, The Journal of urology.

[256]  A. Chou,et al.  Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types , 2010, The American journal of surgical pathology.

[257]  Ximing J. Yang,et al.  Renal Tubulocystic Carcinoma Is Closely Related to Papillary Renal Cell Carcinoma: Implications for Pathologic Classification , 2009, The American journal of surgical pathology.

[258]  C. Pan,et al.  Immunohistochemical and molecular genetic profiling of acquired cystic disease‐associated renal cell carcinoma , 2009, Histopathology.

[259]  C. Pan,et al.  Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas , 2009, Modern Pathology.

[260]  J. Cheville,et al.  Tubulocystic Carcinoma of the Kidney: Clinicopathologic Analysis of 31 Cases of a Distinctive Rare Subtype of Renal Cell Carcinoma , 2009, The American journal of surgical pathology.

[261]  V. Reuter,et al.  Mucinous Tubular and Spindle Cell Carcinoma of the Kidney With Sarcomatoid Change , 2009, The American journal of surgical pathology.

[262]  H. Moch,et al.  Chromophobe Renal Cell Carcinoma: Histomorphologic Characteristics and Evaluation of Conventional Pathologic Prognostic Parameters in 145 Cases , 2008, The American journal of surgical pathology.

[263]  Y. Hayashi,et al.  Mucinous tubular and spindle cell carcinoma with Fuhrman nuclear grade 3: a histological, immunohistochemical, ultrastructural and FISH study. , 2008, Histology and histopathology.

[264]  R. Shah,et al.  Clear Cell Papillary Renal Cell Carcinoma: A Distinct Histopathologic and Molecular Genetic Entity , 2008, The American journal of surgical pathology.

[265]  K. Cooper,et al.  Mucinous tubular and spindle cell carcinoma with aggressive histomorphology--a sarcomatoid variant. , 2008, Human pathology.

[266]  P. Argani,et al.  Translocation renal cell carcinoma , 2008, Cancer.

[267]  Ximing J. Yang,et al.  Tubulocystic Carcinoma of the Kidney: Clinicopathologic and Molecular Characterization , 2008, The American journal of surgical pathology.

[268]  M. Merino,et al.  The Morphologic Spectrum of Kidney Tumors in Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) Syndrome , 2007, The American journal of surgical pathology.

[269]  M. Ladanyi,et al.  Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum , 2007, The American journal of surgical pathology.

[270]  B. Delahunt,et al.  Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma , 2007, Modern Pathology.

[271]  S. Jung,et al.  Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features. , 2007, Annals of diagnostic pathology.

[272]  N. Mittman,et al.  Renal medullary carcinoma. , 2006, Journal of the National Medical Association.

[273]  M. Ladanyi,et al.  Translocation carcinomas of the kidney after chemotherapy in childhood. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[274]  H. Moch,et al.  Spectrum of Epithelial Neoplasms in End-Stage Renal Disease: An Experience From 66 Tumor-Bearing Kidneys With Emphasis on Histologic Patterns Distinct From Those in Sporadic Adult Renal Neoplasia , 2006, The American journal of surgical pathology.

[275]  J. Srigley,et al.  Immunohistochemical Analysis of Mucinous Tubular and Spindle Cell Carcinoma and Papillary Renal Cell Carcinoma of the Kidney: Significant Immunophenotypic Overlap Warrants Diagnostic Caution , 2006, The American journal of surgical pathology.

[276]  S. Bonsib.  T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. , 2005, The Journal of urology.

[277]  J. Cheville,et al.  Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness , 2005, Cancer.

[278]  B. Delahunt,et al.  Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma , 2005, Modern Pathology.

[279]  M. Ladanyi,et al.  Renal Carcinomas With the t(6;11)(p21;q12): Clinicopathologic Features and Demonstration of the Specific Alpha-TFEB Gene Fusion by Immunohistochemistry, RT-PCR, and DNA PCR , 2005, The American journal of surgical pathology.

[280]  M. Peyromaure,et al.  Chromophobe renal cell carcinoma , 2004, Cancer.

[281]  J. Cheville,et al.  Sarcomatoid Renal Cell Carcinoma: An Examination of Underlying Histologic Subtype and an Analysis of Associations With Patient Outcome , 2004, The American journal of surgical pathology.

[282]  Jérôme Couturier,et al.  A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23) , 2003, Oncogene.

[283]  M. Ladanyi,et al.  Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions: A Sensitive and Specific Immunohistochemical Assay , 2003, The American journal of surgical pathology.

[284]  J. Cheville,et al.  Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma , 2003, The American journal of surgical pathology.

[285]  J. Cheville,et al.  An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. , 2002, The Journal of urology.

[286]  S. Suster,et al.  Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis: report of 11 cases including a case with hybrid conventional renal cell carcinoma/ spindle and cuboidal renal cell carcinoma components , 2002, Histopathology.

[287]  W. Linehan,et al.  Renal Tumors in the Birt-Hogg-Dubé Syndrome , 2002, The American journal of surgical pathology.

[288]  M. Ladanyi,et al.  PRCC-TFE3 Renal Carcinomas: Morphologic, Immunohistochemical, Ultrastructural, and Molecular Analysis of an Entity Associated With the t(X;1)(p11.2;q21) , 2002, The American journal of surgical pathology.

[289]  C. Rakozy,et al.  Low-Grade Tubular-Mucinous Renal Neoplasms: Morphologic, Immunohistochemical, and Genetic Features , 2002, Modern Pathology.

[290]  J. Gulcher,et al.  A population‐based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas , 2002, International journal of cancer.

[291]  J. Chan,et al.  Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations. , 2002, Human pathology.

[292]  M. Ladanyi,et al.  Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. , 2001, The American journal of pathology.

[293]  B. Delahunt,et al.  Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. , 2001, Human pathology.

[294]  P. Argani,et al.  The Spectrum of Metanephric Adenofibroma and Related Lesions: Clinicopathologic Study of 25 Cases From the National Wilms Tumor Study Group Pathology Center , 2001, The American journal of surgical pathology.

[295]  Alfons Meindl,et al.  The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25 , 2001, Oncogene.

[296]  P. Humphrey,et al.  Renal Cell Carcinoma With Rhabdoid Features , 2000, The Journal of urology.

[297]  J. Pfeifer,et al.  Renal cell carcinoma with rhabdoid features. , 2000, The American journal of surgical pathology.

[298]  M. Rubin,et al.  Renal oncocytosis: a morphologic study of fourteen cases. , 1999, The American journal of surgical pathology.

[299]  S. Tickoo,et al.  Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. , 1999, The American journal of surgical pathology.

[300]  P. Choyke,et al.  Familial renal oncocytoma: clinicopathological study of 5 families. , 1998, The Journal of urology.

[301]  Damian Smedley,et al.  Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma , 1997, Oncogene.

[302]  P. Russo,et al.  Renal oncocytoma: a clinicopathologic study of 70 cases. , 1997, The American journal of surgical pathology.

[303]  G. Kovacs,et al.  Binucleated cells in a human renal cell carcinoma with 34 chromosomes. , 1988, Cancer genetics and cytogenetics.

[304]  D. Grignon,et al.  Papillary Renal Neoplasm With Reverse Polarity , 2019, The American journal of surgical pathology.

[305]  Chad A. LaGrange,et al.  NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[306]  O. Hes,et al.  Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms. , 2018, The Journal of molecular diagnostics : JMD.

[307]  J. McKenney,et al.  Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase–deficient Renal Cell Carcinoma , 2018, The American journal of surgical pathology.

[308]  S. Dhanasekaran,et al.  Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays , 2018, Modern Pathology.

[309]  A. Ishiko,et al.  Skin lesions of Birt-Hogg-Dubé syndrome: Clinical and histopathological findings in 31 Japanese patients who presented with pneumothorax and/or multiple lung cysts. , 2018, Journal of dermatological science.

[310]  D. Berney,et al.  Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity , 2017, The American journal of surgical pathology.

[311]  R. Alaghehbandan,et al.  TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Amog Xp11 Translocation Cancers. , 2017, The American journal of surgical pathology.

[312]  Quyen N. Do,et al.  Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade. , 2017, Cancer discovery.

[313]  S. Moreau,et al.  [Tubulocystic renal cell carcinoma with poorly differentiated foci]. , 2017, Annales de pathologie.

[314]  Jonathan I. Epstein,et al.  WHO Classification of of Tumours of the Urinary System and Male Genital Organs , 2016 .

[315]  J. Cheville,et al.  Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression. , 2016, The Journal of urology.

[316]  P. Humphrey,et al.  Genetic alterations in renal cell carcinoma with rhabdoid differentiation. , 2015, Human pathology.

[317]  M. Amin,et al.  Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma , 2015, Modern Pathology.

[318]  B. Delahunt,et al.  Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. , 2014, The American journal of surgical pathology.

[319]  L. Truong,et al.  Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. , 2014, Human pathology.

[320]  R. Shah,et al.  Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. , 2008, Human pathology.

[321]  P. di Sant'Agnese,et al.  Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid differentiation. , 2008, International journal of clinical and experimental pathology.

[322]  A. Billis.  Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. , 2004, International braz j urol : official journal of the Brazilian Society of Urology.

[323]  S. Tickoo,et al.  Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. , 1999, The American journal of surgical pathology.

[324]  E. Schröck,et al.  Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. , 1994, The American journal of pathology.